Dr. Quigg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Michigan St NE
Fl 10
Grand Rapids, MI 49503Phone+1 616-267-1925
Education & Training
- Indiana University School of MedicineFellowship, Pediatric Hematology/Oncology, 2009 - 2013
- Indiana University School of MedicineResidency, Pediatrics, 2006 - 2009
- Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2006
Certifications & Licensure
- MI State License 2020 - 2026
- TX State License 2013 - 2025
- IN State License 2009 - 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Roles: Principal Investigator, Contact
- Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors Start of enrollment: 2019 Apr 03
Roles: Contact, Principal Investigator
- Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma Start of enrollment: 2019 Mar 01
Roles: Contact
Publications & Presentations
PubMed
- Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas.Jonathan D Bender, Sudarshawn Damodharan, Christian M Capitini, Amy Moskop, Keri Toner
Blood Advances. 2024-08-13 - 1 citationsPathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation.Matt S Zinter, Christopher C Dvorak, Madeline Y Mayday, Gustavo Reyes, Miriam R Simon
Nature Medicine. 2024-07-01 - 2 citationsAntiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II intervent...Michael D Keller, Patrick J Hanley, Yueh-Yun Chi, Paibel Aguayo-Hiraldo, Christopher C Dvorak
Nature Communications. 2024-04-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: